Kevin Quon
Insider ownership, small-cap, long-term horizon, dividend investing

Pacific Biosciences Of California: An Underrated DNA Sequencer Gaining Traction

There are few technologies that have the potential to advance and improve the understanding of science. Pacific Biosciences of California, Inc. (PACB) is one such name to do this. The company has developed a platform capable of improving the study of DNA synthesis, composition, structure, and regulation. The company markets an integrated system for genetic analysis known as the PacBio RS II.

The system boasts the longest base pair read lengths in the industry thereby providing the most complete picture of a typical sequence. The company competes with other more established players in the industry including Illumina (ILMN) and Life Technologies (acquired by Thermo Fisher Scientific). A sample look at the typical read length of its...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details